Genentech, Parvus Therapeutics Launch Up-to-$800M Autoimmune Collaboration

Genentech, a Member of the Roche Group, today launched an up-to-$800 million partnership with Parvus Therapeutics to develop, manufacture, and commercialize new treatments for inflammatory bowel disease (IBD), autoimmune liver diseases (ALD), and celiac...

Brain network activity can improve in epilepsy patients after surgery

Credit: Vanderbilt University Medical Center Successful epilepsy surgery can improve brain connectivity similar to patterns seen in people without epilepsy, according to a new study published in...

Scientists unravel how intelligent neural network predicts the functions of proteins

Intelligent virtual companions like Alexa, Siri, and Google Assistant have long become integrated into our everyday lives. And intelligent computational programs, so-called algorithms, have also evolved as an integral tool in scientific research. The huge...

BioTechnology Stocks | There’s A Good Reason Investors Love These Shares – MicroSmallCap

Biotechnology stocks offer investors the potential to profit from the next generation of treatments. And because treatments are vast—covering everything from serious illness to cosmetic enhancements, investors are afforded a lot of choices. Because of...

Prostate Cancer Target Blockade Tackles Elusive Onocogene

Targeting a protein that is essential for supporting the MYC oncogene could offer a new therapeutic approach to preventing prostate cancer (PC) metastasis, according to early research results in laboratory-grown cells and mouse models....

Exploring the possibility of a broadly effective dengue vaccine

Dengue is on the rise, with about 20,000 patients dying each year from this mosquito-borne disease, yet despite ongoing efforts a broadly effective dengue vaccine is not available. The complex challenges, current status of...

PDS Biotechnology Reports First Quarter 2019 Financial Results and Provides Business Update – Yahoo...

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)--sm Mt(0.8em)--sm" type="text" content="BERKELEY HEIGHTS, N.J., May 14, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (“PDS Biotechnology”) (PDSB), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products,...

Global Biotechnology Market 2019 – Industry Survey, Market Size, Competitive Trends, Outlook and Forecasts...

“Market Research Outlet follows complete research methodology focused on providing the most precise Biotechnology market analysis.” The company supports a data separate model which helps the business to estimate the Biotechnology market dynamics and provide...

Make biotech sexy again – Letters – The Star Online

NOT so long ago, biotechnology was touted as an industry that promised lucrative job opportunities. Many were taken by that promise. They lined up at colleges to enrol for the course. Universities competed to...

Genomics’ “Green” Future

The National Human Genome Research Institute (NHGRI) is nearing the halfway point of a major strategic planning process, one that aims to publish a “2020 vision for genomics” in late 2020. The new plan...